Mairs & Power Inc’s Edwards Lifesciences EW Stock Holding History

Mairs & Power Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,938	Closed	-$277K	–	224
2023 Q2	$277K	Sell	2,938 -560	-16%	-$48.7K	﹤0.01%	200
2023 Q1	$289K	Buy	+3,498	New	+$275K	﹤0.01%	206
2022 Q1	–	Sell	-1,593	Closed	-$206K	–	221
2021 Q4	$206K	Buy	+1,593	New	+$186K	﹤0.01%	212
2020 Q2	–	Sell	-4,443	Closed	-$279K	–	207
2020 Q1	$279K	Hold	4,443	–	–	﹤0.01%	175
2019 Q4	$346K	Buy	4,443 +483	+12%	+$37.7K	﹤0.01%	179
2019 Q3	$290K	Hold	3,960	–	–	﹤0.01%	177
2019 Q2	$244K	Hold	3,960	–	–	﹤0.01%	190
2019 Q1	$253K	Hold	3,960	–	–	﹤0.01%	186
2018 Q4	$202K	Hold	3,960	–	–	﹤0.01%	194
2018 Q3	$230K	Buy	+3,960	New	+$194K	﹤0.01%	195

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Mairs & Power Inc's EW Position: Q3 2023 in Review

Mairs & Power Inc sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 2,938 shares — an estimated $277K sold.

Mairs & Power Inc first reported a position in EW in Q3 2018 and held it in 10 quarters. The position peaked at $346K in Q4 2019. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

Mairs & Power Inc reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
Mairs & Power Inc sold 2,938 Edwards Lifesciences shares in Q3 2023, an estimated $277K.
Mairs & Power Inc first reported a position in Edwards Lifesciences in Q3 2018 and held it in 10 quarters.
Mairs & Power Inc's Edwards Lifesciences position peaked at $346K in Q4 2019.
1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Mairs & Power Inc's 13F filing for Q3 2023, filed 14 Nov 2023.